Murphy Capital Management Inc. Has $2.66 Million Stake in UnitedHealth Group Inc (NYSE:UNH)

Murphy Capital Management Inc. trimmed its stake in UnitedHealth Group Inc (NYSE:UNH) by 2.0% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 12,242 shares of the healthcare conglomerate’s stock after selling 247 shares during the period. Murphy Capital Management Inc.’s holdings in UnitedHealth Group were worth $2,660,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently bought and sold shares of UNH. Nuveen Asset Management LLC grew its position in UnitedHealth Group by 1,354.6% in the 2nd quarter. Nuveen Asset Management LLC now owns 8,540,562 shares of the healthcare conglomerate’s stock worth $2,083,983,000 after purchasing an additional 7,953,416 shares during the last quarter. Thoroughbred Financial Services LLC grew its position in UnitedHealth Group by 25,321.4% in the 2nd quarter. Thoroughbred Financial Services LLC now owns 1,922,872 shares of the healthcare conglomerate’s stock worth $192,287,000 after purchasing an additional 1,915,308 shares during the last quarter. Boston Partners grew its position in UnitedHealth Group by 160.8% in the 2nd quarter. Boston Partners now owns 2,550,998 shares of the healthcare conglomerate’s stock worth $622,942,000 after purchasing an additional 1,572,711 shares during the last quarter. Sanders Capital LLC grew its position in UnitedHealth Group by 50.2% in the 2nd quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock worth $1,255,689,000 after purchasing an additional 1,546,140 shares during the last quarter. Finally, Viking Global Investors LP grew its position in UnitedHealth Group by 28.6% in the 2nd quarter. Viking Global Investors LP now owns 4,812,185 shares of the healthcare conglomerate’s stock worth $1,174,221,000 after purchasing an additional 1,071,149 shares during the last quarter. Institutional investors own 85.66% of the company’s stock.

Several analysts have issued reports on UNH shares. Deutsche Bank started coverage on shares of UnitedHealth Group in a research report on Thursday, September 12th. They issued a “hold” rating and a $263.00 price target on the stock. Jefferies Financial Group lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $300.00 to $235.00 in a research report on Thursday. Credit Suisse Group set a $293.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Thursday, August 29th. BMO Capital Markets lowered shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $292.00 to $249.00 in a research report on Monday, September 30th. Finally, Cantor Fitzgerald set a $310.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $283.78.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total value of $3,063,720.00. Following the transaction, the director now directly owns 61,309 shares in the company, valued at $15,652,800.79. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $233.40, for a total transaction of $583,500.00. Following the completion of the transaction, the director now owns 187,979 shares in the company, valued at $43,874,298.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 24,000 shares of company stock worth $5,924,120. Company insiders own 0.87% of the company’s stock.

Shares of UnitedHealth Group stock traded up $1.42 during trading on Friday, hitting $225.15. 2,518,097 shares of the company’s stock traded hands, compared to its average volume of 4,519,363. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67. The firm’s fifty day moving average price is $227.48 and its 200 day moving average price is $240.20. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The company has a market cap of $208.59 billion, a PE ratio of 17.48, a PEG ratio of 1.17 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating the Zacks’ consensus estimate of $3.46 by $0.14. The firm had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the previous year, the business earned $3.14 earnings per share. As a group, equities research analysts anticipate that UnitedHealth Group Inc will post 14.83 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a $1.08 dividend. The ex-dividend date of this dividend was Friday, September 13th. This represents a $4.32 dividend on an annualized basis and a yield of 1.92%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Analyzing a company’s cash flow statement

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.